Rieu I, et al. - Using a randomized, double-blind, placebo-controlled trial, the authors examined the effect of incobotulinum toxin A (Xeomin) in the treatment of foot dystonia in parkinsonian patients. For improving the clinical state of parkinsonian patients with plantar flexion of toe dystonia, Btx injections were effective.